Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Italy

European Innovation Council · Running

PHIRE Photoacoustic imaging and artificial intelligence-based theranostic approach for cancer

Coordinator
Ospedale San Raffaele SRL, Italy
Runs
1 September 2023 to 31 December 2026
Status
Running
EU funding
€2.1m
Total cost
€2.1m
Partners
5 organisations in 4 countries
Type
European Innovation Council
Grant agreement
101113193

What the project is doing

In the project's own words, from its summary on CORDIS.

Health programs crave for diagnostic imaging and eradication of chemoresistant neoplastic lesions smaller than 1 mm of size. PHIRE, based on the outcomes from EDIT (FET-OPEN-RIA, GA#801126), aims at bringing closer to market a novel high-resolution theranostic medical device effective in the clinical applications for lesions <1 mm, ready for application in human bladder cancer and effective both in male and female patients.

The PHIRE solution will be developed using swine model and will include:- an add-on module for pre-existing off-the shelf photoacoustic device allowing to perform photoacoustic imaging of hollow organs located deeper in human body, designed to be used in combination with - an artificial intelligence-assisted prediction map for the image-guided gold nanorods assisted photo-thermal therapy,- a large-scale synthesis of urine-stable gold nanorods for clinical use.

The adoption for clinical applications of this new device will reduce the frequency of the bladder tumor relapse and the number of patients with relapsing tumor, with a drastic positive impact on the quality of life of patients while reducing the social cost of the management of patients. Furthermore, PHIRE’s results will open up the way for the deployment of theranostic application against lesions <1 mm in other hollow human organs.

PHIRE innovative solutions will also be applicable to other markets, such as that of photoacoustic and diagnostic imaging, gold nanoparticles, cystoscopy and medical software.""

Topics

Who is involved

OrganisationCityCountryRole
Ospedale San Raffaele SRLMilanoItalyCoordinator
MetaSint-Joost-Ten-NodeBelgiumParticipant
Alma Mater Studiorum - Universita Di BolognaBolognaItalyParticipant
Fujifilm Sonosite BVAmsterdamNetherlandsParticipant
Ascend Technologies LimitedSouthamptonUnited KingdomAssociatedpartner

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI